newsfilter
← Latest News
Business Wire·

Epizyme Announces Updates to Its Board of Directors

Epizyme, Inc. (NASDAQ:EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced two appointments to the Company's Board of Directors: clinical oncology executive, Roy A. B